Saturday, September 23, 2023 - Saturday, September 23, 2023
About this Event
4100 Admiralty Way, Marina Del Rey, CA 90292
We are sold out for the in-person attendance.
Online Registration for virtual attendance will be closed at 12:00 PM (PST) on Friday, September 22, 2023.
After the online registration closes, please email ccpd@mednet.ucla.edu or call 310-794-2620 to register.
Heart failure affects approximately six million Americans and is the most common diagnosis for acute hospitalization in patients over 65 years. Over the next decade, we will see a dramatic increase in the number of patients in the community with advanced heart failure who can benefit from advanced therapies for complex cardiac disease. Academic medical centers, such as UCLA, have an opportunity to integrate treatment advances into a comprehensive patient-centered heart failure management program. UCLA Health wants to enhance the role of the primary care physician and primary cardiologist as the central provider for continuity of care for these complex heart failure patients.
The 11th Annual UCLA Heart Failure Symposium 2023 will:
1. Discuss general heart failure treatment options including short and long term mechanical circulatory support therapy, heart transplantation, pulmonary hypertension management, high risk percutaneous and structural interventions, and complex congenital heart disease management.
2. Emphasize the need for developing networks linking academic centers with community physicians to manage these patients through the evolution of their disease pre and post advanced cardiac intervention.
3. Discuss heart failure therapies in cardio-oncology, amyloidosis and new medication updates, as well as address patient and care-provider’s specific needs and perspectives.
Target Audience
Family practitioners, internists, cardiologists, pediatricians, nurses and all other healthcare professionals taking care of heart failure patients, as well as the interested lay public.
REGISTRATION INFORMATION
Online Registration for virtual attendance will be closed at 12:00 PM (PST) on Friday, September 22, 2023.
After the online registration closes, please email ccpd@mednet.ucla.edu or call 310-794-2620 to register.
In-person registration includes access to the course materials, breakfast, patio lunch and reception at the meeting site.
Virtual registration includes access to the live stream virtual conference. All registrants (live or virtual) will receive access to the conference recordings up to 3 weeks following the program.
Course Fee
(SOLD OUT) $75 Live In-Person Registration
$75 Live Virtual Registration
Refunds
Due to the low enrollment fee, no refunds will be given for this conference.
Questions
If you have questions about enrollment, please email ccpd@mednet.ucla.edu or call (310) 794-2620.
LOCATION & PARKING
Marina del Rey Marriott - California Ballroom
4100 Admiralty Way
Marina del Rey, CA, 90292
(310) 301-3000
Valet Parking Fee: $25
EXHIBITOR INFORMATION
Please email ccpd@mednet.ucla.edu.
OBJECTIVES
At the conclusion of the program participants will be able to:
ACCREDITATION
The David Geffen School of Medicine at UCLA is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The David Geffen School of Medicine at UCLA, designates this live activity for a maximum of 7.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The California State Board of Registered Nursing accepts courses approved for the AMA PRA Category 1 Credits™ as meeting the continuing education requirements for license renewal. Nurses from states other than California should inquire with their local State Board for specific continuing education policies.
DISCLOSURES
The FDA has issued a concept paper that classifies commercial support of scientific and educational programs as promotional unless it can be affirmed that the program is “truly independent” and free of commercial influence. In addition to independence, the FDA requires that non-promotional, commercially supported education be objective, balanced and scientifically rigorous. The policy further states that all potential conflicts of interest of the CME staff and faculty be fully disclosed to the program’s participants. In addition, Accreditation Council for Continuing Medical Education policy mandates that the provider adequately manage all identified potential conflicts of interest prior to the program. UCLA fully endorses the letter and spirit of these concepts.